⌘K

Login Start Free

Home/Filings/4/0001127602-12-024125

4//SEC Filing

AMGEN INC 4

Accession 0001127602-12-024125

$AMGNCIK 0000318154operating

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 6:14 PM ET

Size

27.9 KB

Accession

0001127602-12-024125

Insider Transaction Report

Form 4

Period: 2012-08-06

Director

Transactions

Tax Payment
Common Stock
2012-08-06$82.21/sh−3,805$312,809→ 40,603 total
Tax Payment
Common Stock
2012-08-06$82.21/sh−3,068$252,220→ 34,972 total
Exercise/Conversion
Nqso (Right to Buy)
2012-08-06−5,000→ 0 total
Exercise: $58.43From: 2010-04-26Exp: 2020-04-26→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2012-08-06$62.55/sh+5,000$312,750→ 24,408 total
Exercise/Conversion
Nqso (Right to Buy)
2012-08-06−5,000→ 0 total
Exercise: $42.13From: 2008-04-29Exp: 2015-04-29→ Common Stock (5,000 underlying)
Exercise/Conversion
Nqso (Right to Buy)
2012-08-06−5,000→ 0 total
Exercise: $50.44From: 2009-04-28Exp: 2016-04-28→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock
2012-08-06$50.44/sh+5,000$252,200→ 34,408 total
Exercise/Conversion
Common Stock
2012-08-06$58.43/sh+5,000$292,150→ 39,408 total
Tax Payment
Common Stock
2012-08-06$82.21/sh−2,563$210,704→ 38,040 total
Tax Payment
Common Stock
2012-08-06$82.21/sh−3,327$273,513→ 28,091 total
Exercise/Conversion
Common Stock
2012-08-06$42.13/sh+5,000$210,650→ 29,408 total
Exercise/Conversion
Common Stock
2012-08-06$54.69/sh+5,000$273,450→ 44,408 total
Exercise/Conversion
Nqso (Right to Buy)
2012-08-06−5,000→ 0 total
Exercise: $62.55From: 2007-04-26Exp: 2014-04-26→ Common Stock (5,000 underlying)
Exercise/Conversion
Nqso (Right to Buy)
2012-08-06−5,000→ 0 total
Exercise: $54.69From: 2011-04-25Exp: 2021-04-25→ Common Stock (5,000 underlying)
Tax Payment
Common Stock
2012-08-06$82.21/sh−3,554$292,174→ 31,418 total

Footnotes (1)

[F1]These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMGEN INC

CIK 0000318154

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000318154

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 6:14 PM ET
Size: 27.9 KB

View on SEC.gov